![]() |
市場調査レポート
商品コード
1566203
透析の市場規模、シェア、成長分析、タイプ別、製品・サービス別、エンドユーザー別、地域別 - 産業予測、2024年~2031年Dialysis Market Size, Share, Growth Analysis, By Type (Hemodialysis, Peritoneal Dialysis), By Products and Services (Equipment, Consumables), By End User (In-center Dialysis, Home Dialysis), By Region - Industry Forecast 2024-2031 |
||||||
|
透析の市場規模、シェア、成長分析、タイプ別、製品・サービス別、エンドユーザー別、地域別 - 産業予測、2024年~2031年 |
出版日: 2024年10月01日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
世界の透析の市場規模は、2022年に1,108億米ドルとなり、2023年の1,158億2,000万米ドルから、2031年までには1,624億5,000万米ドルに成長し、予測期間(2024年~2031年)のCAGRは4.32%で成長する見通しです。
透析市場は、慢性腎臓病の有病率の大幅な上昇により、腎クリニックでの治療を求める患者が増加しているため、力強い成長を遂げています。特に米国メディケア&メディケイドサービスセンター(CMS)を中心とする民間および政府機関による支払い政策の強化がこの傾向を支えています。例えば、2019年、CMSは約7,000の末期腎疾患(ESRD)プロバイダーに血液透析費用を賄うためにおよそ103億米ドルのメディケア償還金を割り当てました。このような財政的支援は、今後数年間の市場拡大に拍車をかけると予想されます。米国国立衛生研究所(NIH)によると、COVID患者の約5%が腎代替療法を必要としており、多くの重症患者が急性腎障害に苦しんでいます。このような緊急のニーズに応えるため、病院では腎治療機器の導入が進んでおり、市場の成長軌道をさらに後押ししています。その結果、米国市場情勢は持続的な成長が見込まれ、今後の予測期間においても安定したCAGRを達成すると予測されています。これは、差し迫った医療需要と腎臓関連疾患の治療状況の進化を反映しています。
Global Dialysis Market size was valued at USD 110.80 billion in 2022 and is poised to grow from USD 115.82 billion in 2023 to USD 162.45 billion by 2031, growing at a CAGR of 4.32% during the forecast period (2024-2031).
The dialysis market is experiencing robust growth due to a significant rise in chronic kidney disease prevalence, leading to more patients seeking treatment at renal clinics. Enhanced payment policies from commercial and government entities, particularly the Centers for Medicare & Medicaid Services (CMS), support this trend; for instance, in 2019, CMS allocated roughly US$ 10.3 billion in Medicare reimbursements to around 7,000 end-stage renal disease (ESRD) providers to cover hemodialysis costs. This financial backing is expected to fuel market expansion in the coming years. Additionally, the recent COVID-19 pandemic has exacerbated the demand for renal equipment, as many critically ill patients suffer from acute kidney injury, with about 5% of COVID cases requiring renal replacement therapy according to the National Institutes of Health (NIH). Hospitals are increasingly adopting renal therapy equipment to meet this urgent need, further driving the market's growth trajectory. As a result, the US dialysis market is positioned for sustained growth, projected to achieve a consistent compound annual growth rate (CAGR) in the upcoming forecast period, reflecting both the pressing healthcare demands and the evolving treatment landscape for kidney-related disorders.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dialysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Dialysis Market Segmental Analysis
Global Dialysis Market is segmented by Type, Products and Services, End User, and Region. Based on Type, the market is segmented into Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)). Based on Products and Services, the market is segmented into Services, Equipment (Dialysis Machines, Water Treatment Systems, Others), Consumables (Dialyzers, Catheters, Others), Dialysis Drugs. Based on End User, the market is segmented into In-center Dialysis, Home Dialysis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Dialysis Market
The escalating prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is a significant market driver for the global dialysis market. As the burden of ESRD increases, necessitating long-term renal therapies or transplants, healthcare systems face immense financial pressures, thereby escalating the demand for efficient dialysis services. With approximately 15% of the U.S. population affected by CKD, the urgency for accessible renal care is heightened. Additionally, the expansion of nephrology specialists and renal care facilities in developed nations, coupled with investments aimed at establishing dialysis centers in emerging markets like India and China, underscores a robust growth trajectory. This demand for affordable yet effective renal treatments is projected to fuel substantial market revenue generation, making it a pivotal factor in the global dialysis landscape.
Restraints in the Global Dialysis Market
The global dialysis market faces significant restraint due to the growing preference for kidney transplantation as a treatment for end-stage renal disease (ESRD) and stage III chronic kidney disease (CKD). Patients often opt for transplantation over dialysis, attracted by the potential for better long-term outcomes and improved quality of life. Favorable reimbursement policies make kidney transplantation a more financially viable option, further driving this shift. Additionally, the rising costs associated with renal therapy, exacerbated by the coronavirus pandemic-especially in countries like India-may deter patients from opting for dialysis, ultimately hindering market growth and adoption of dialysis treatments.
Market Trends of the Global Dialysis Market
The Global Dialysis market is witnessing a significant trend of transitioning from traditional clinic-based care to homecare settings, driven by patient preferences, especially in developed economies. This shift is complemented by government initiatives, particularly in the United States, aimed at promoting cost-effective home treatment options for end-stage renal disease (ESRD). The emergence of advanced renal care technologies, including innovative dialysis machines and efficient dialyzers, is further propelling market growth, with key players like B.Braun and Fresenius Kabi leading the charge in product development. The focus on enhancing accessibility to homecare is expected to attract a growing number of patients seeking convenient and personalized treatment options, heralding a transformative phase in the dialysis landscape.